Tomm20l Inhibitors
The chemical class known as Tomm20l Inhibitors comprises a diverse array of compounds that can potentially inhibit the Tomm20l protein through various mechanisms. Tamoxifen, an estrogen receptor modulator, may interfere with estrogen signaling, downregulating gene expression linked to Tomm20l and suppressing its activation. Rapamycin and AZD8055, both mTOR inhibitors, can modulate the mTOR pathway, negatively impacting Tomm20l activation and functionality.
GW9662, a selective PPARγ antagonist, has the potential to inhibit Tomm20l by disrupting PPARγ-mediated signaling pathways. Mitoxantrone, a topoisomerase inhibitor, may inhibit Tomm20l by affecting DNA replication and repair processes, inducing cellular stress. Etomoxir, a CPT-1 inhibitor, can potentially inhibit Tomm20l by disrupting fatty acid oxidation and altering cellular metabolism. Wortmannin, a PI3K inhibitor, may inhibit Tomm20l by interfering with PI3K-dependent signaling pathways.
AG-490, a JAK2 inhibitor, and GSK-J4, a JMJD3/UTX inhibitor, may inhibit Tomm20l by disrupting JAK2-mediated signaling and affecting histone demethylation, respectively. SB203580, a p38 MAPK inhibitor, can inhibit Tomm20l by blocking the p38 MAPK pathway. Trichostatin A, an HDAC inhibitor, can affect Tomm20l by altering histone acetylation. PD98059, a MEK inhibitor, may inhibit Tomm20l by disrupting the MEK/ERK pathway.
The diversity in mechanisms displayed by Tomm20l Inhibitors highlights the intricate regulation of Tomm20l and the interconnectedness of cellular pathways influencing its activation. Researchers can employ these inhibitors to unravel the complex regulatory networks associated with Tomm20l and gain insights into potential avenues for modulating Tomm20l function in cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen, an estrogen receptor modulator, may inhibit Tomm20l by interfering with estrogen signaling. Its anti-estrogenic effects can downregulate gene expression linked to Tomm20l, potentially suppressing its activation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin, an mTOR inhibitor, can inhibit Tomm20l by modulating the mTOR pathway. This interference may lead to downstream effects that negatively impact Tomm20l activation and functionality. | ||||||
GW 9662 | 22978-25-2 | sc-202641 | 5 mg | $70.00 | 30 | |
GW9662, a selective PPARγ antagonist, can potentially inhibit Tomm20l by interfering with PPARγ-mediated signaling pathways. This disruption may lead to downstream effects that negatively impact Tomm20l activation. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone, a topoisomerase inhibitor, can inhibit Tomm20l by affecting DNA replication and repair. Its interference with these processes may lead to cellular stress, negatively impacting Tomm20l activation and function. | ||||||
(+)-Etomoxir sodium salt | 828934-41-4 | sc-215009 sc-215009A | 5 mg 25 mg | $151.00 $506.00 | 3 | |
Etomoxir, a CPT-1 inhibitor, can potentially inhibit Tomm20l by disrupting fatty acid oxidation. This interference may lead to altered cellular metabolism, negatively impacting Tomm20l activation and functionality. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, a PI3K inhibitor, can inhibit Tomm20l by disrupting PI3K-dependent signaling pathways. This interference may lead to downstream effects that negatively impact Tomm20l activation and functionality. | ||||||
AG-490 | 133550-30-8 | sc-202046C sc-202046A sc-202046B sc-202046 | 5 mg 50 mg 25 mg 10 mg | $84.00 $329.00 $223.00 $87.00 | 35 | |
AG-490, a JAK2 inhibitor, may inhibit Tomm20l by disrupting JAK2-mediated signaling pathways. This interference may lead to downstream effects that negatively impact Tomm20l activation and functionality. | ||||||
GSK-J4 | 1373423-53-0 | sc-507551 | 100 mg | $1275.00 | ||
GSK-J4, a JMJD3/UTX inhibitor, can potentially inhibit Tomm20l by affecting histone demethylation. This alteration in epigenetic regulation can influence gene expression, potentially suppressing Tomm20l activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, can inhibit Tomm20l by blocking the p38 MAPK pathway. This interference disrupts downstream events crucial for Tomm20l activation, negatively impacting its functionality. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, an HDAC inhibitor, can inhibit Tomm20l by affecting histone acetylation. This alteration in chromatin structure may lead to transcriptional changes, suppressing Tomm20l expression and activity. | ||||||